Biotech Values

[BTH]

INFI was the result of a reverse merger.

I dont really care too much for Martin but I am interested in what the company does; lots of orphan stuff.

By the looks of the trading, its going to be nearly impossible to trade the stock unless they do some sort of financing to add liquidity. Basically, the thing is so thin, and market cap small right now, that if they ever hit in one of their indications, as the capital is structured now, the stock would go through the roof.